Task: Answer the multiple-choice question.
Question: Which drug exhibits a 15.255% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
[a] Cc1cc2ncc(C(N)=O)cn2n1
[b] Cc1cc(NC(=S)N(CCN2CCCCC2)Cc2ccco2)ccc1Cl
[c] CC(C)C(=O)Nc1ccc(O)c(-c2csc(N)n2)c1
[d] O=c1oc(-c2ccccc2Cl)nc2ccsc12
Answer: c. CC(C)C(=O)Nc1ccc(O)c(-c2csc(N)n2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C(=O)Nc1ccc(O)c(-c2csc(N)n2)c1
CC(C)C(=O)Nc1ccc(O)c(-c2csc(N)n2)c1
N-[3-(2-amino-1,3-thiazol-4-yl)-4-hydroxyphenyl]-2-methylpropanamide